Literature DB >> 11257789

[Muscle involvement of Stormorken's syndrome].

M Mizobuchi1, C Tanaka, K Sako, N Murakami, A Nihira, T Abe, Y Tateno, T Takahashi, I Nonaka.   

Abstract

We described two patients, a mother and daughter, of Stormorken's syndrome. The syndrome is characterized clinically by autosomal dominant inheritance, congenital miosis, thrombocytopenia, asplenia and muscle weakness. Both patients had bleeding tendency, ichthyosis of arms, and muscle weakness. The daughter additionally had short stature (146 cm), low body weight (32 kg) and muscle cramp. Neurological findings of the patients included migraine-like headache, cognitive dysfunction, limitation of upward and lateral gaze, and amydriasis. Femoral muscle MRI of the daughter demonstrated decreased volume with patchy high intensity areas in the hamstrings. A muscle biopsy from the daughter showed myogenic changes with muscle fiber necrosis and regeneration, variation in fiber size, tubular aggregates in approximately 5% of fibers, and fibrous tissue proliferation. Dystrophin, dystrophin-associated proteins and dysferlin were normally expressed. Although both patients had elevated creatine kinase levels and generalized muscle wasting, muscle weakness was mild with slow progression. A certain membrane defect in the platelet and muscle fiber might be responsible for the pathogenesis of this syndrome.

Entities:  

Mesh:

Year:  2000        PMID: 11257789

Source DB:  PubMed          Journal:  Rinsho Shinkeigaku        ISSN: 0009-918X


  4 in total

Review 1.  Diseases caused by mutations in ORAI1 and STIM1.

Authors:  Rodrigo S Lacruz; Stefan Feske
Journal:  Ann N Y Acad Sci       Date:  2015-10-15       Impact factor: 5.691

Review 2.  Role of STIM1/ORAI1-mediated store-operated Ca2+ entry in skeletal muscle physiology and disease.

Authors:  Antonio Michelucci; Maricela García-Castañeda; Simona Boncompagni; Robert T Dirksen
Journal:  Cell Calcium       Date:  2018-10-30       Impact factor: 6.817

3.  York platelet syndrome is a CRAC channelopathy due to gain-of-function mutations in STIM1.

Authors:  Thomas Markello; Dong Chen; Justin Y Kwan; Iren Horkayne-Szakaly; Alan Morrison; Olga Simakova; Irina Maric; Jay Lozier; Andrew R Cullinane; Tatjana Kilo; Lynn Meister; Kourosh Pakzad; William Bone; Sanjay Chainani; Elizabeth Lee; Amanda Links; Cornelius Boerkoel; Roxanne Fischer; Camilo Toro; James G White; William A Gahl; Meral Gunay-Aygun
Journal:  Mol Genet Metab       Date:  2014-12-24       Impact factor: 4.797

4.  Activating mutations in STIM1 and ORAI1 cause overlapping syndromes of tubular myopathy and congenital miosis.

Authors:  Vasyl Nesin; Graham Wiley; Maria Kousi; E-Ching Ong; Thomas Lehmann; David J Nicholl; Mohnish Suri; Nortina Shahrizaila; Nicholas Katsanis; Patrick M Gaffney; Klaas J Wierenga; Leonidas Tsiokas
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-03       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.